Item 1.01. Entry Into Material Agreement
On
The information furnished pursuant to Item 1.01 on this Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.
The foregoing summary of the Agreement is qualified in its entirety by the full
text of the Agreement, a copy of which will be filed as an exhibit, with certain
portions subject to confidential treatment, to the Company's Annual Report on
Form 10-K for the year ended
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Press Release, datedDecember 28, 2020 issued byY-mAbs Therapeutics, Inc. 104 Interactive Data File (embedded within the Inline XBRL document).
© Edgar Online, source